Siobhan Calafiore

1 month ago | thelimbic.com | Siobhan Calafiore

Comprehensive occupational histories should become a standard element of respiratory consultations to increase diagnosis of workplace-acquired COPD, the TSANZ ASM heard. Speaking at TSANZ 2025 on Saturday, Sydney-based respiratory physician Professor Deborah Yates stressed the importance of early diagnosis so that workers could be removed from harmful exposure, with the health benefits of doing so documented in industries such as coal mining and stonemasonry.

2 months ago | thelimbic.com | Siobhan Calafiore

Reduced levels of protein-bound skin ceramides in early life might help predict the development of atopic dermatitis and inform prevention strategies, an Australian study suggests. Melbourne researchers, led by the University of Melbourne’s Allergy and Lung Health Unit, said their findings suggested these lipids might have a role in the pathogenesis of atopic dermatitis (AD) and be useful predictive biomarkers.

2 months ago | thelimbic.com | Siobhan Calafiore

Dermatologists have plenty to look forward to on the conference agenda in 2025, with a bumper crop of local and international meetings alongside must-see events from the limbic on the calendar. The American Academy of Dermatology 2025 meeting in March promises to sharpen dermatologic expertise with a comprehensive program led by dermatology experts and broaden horizons through connections with peers and industry leaders.

Jan 20, 2025 | thelimbic.com | Siobhan Calafiore

Most Australasian patients receiving routine care for inflammatory bowel disease report having mild to no perceived burden of disease, while those with a greater perceived burden benefit from therapeutic escalation, new data suggest. Australian gastroenterologists and scientists set out to develop and explore a novel patient-perceived burden of disease (PPBoD) score in a real-world IBD cohort, drawing from the Crohn Colitis Care Registry.

Jan 13, 2025 | thelimbic.com | Siobhan Calafiore

Australia’s first national registry for idiopathic inflammatory myopathies is enrolling myositis centres across the country to help improve the management and outcomes of Australian patients and contribute to research globally. Writing in the Internal Medicine Journal [link here], Australian clinicians said the intention of the Australian Myositis Registry (AMR) in its primary launch phase is to have at least one site in each state and territory.